An expanding tissue-culture laboratory with locations in Washington and Canada has entered into a joint venture with Australis Capital, a U.S. spinoff of Canadian marijuana producer Aurora Cannabis. 3 Rivers Biotech Inc., an agricultural technology company that specializes in commercial-scale micropropagation for marijuana, hemp and traditional crops including vegetables and fruit, will own 85% of… Continue reading Canadian biotech firm forms JV with Australis Capital to expand capabilities in U.S.
Category: Hemp Stocks & Public Companies
MJBizCon announces return to Las Vegas Oct. 20-22
MJBizCon will return as a live, in-person event in Las Vegas this October, barring any unforeseen developments related to the coronavirus pandemic, Marijuana Business Daily announced Monday. The 10th annual cannabis trade show, the largest in the industry, is scheduled to be held at the Las Vegas Convention Center and will include an online component… Continue reading MJBizCon announces return to Las Vegas Oct. 20-22
Lucky Strike’s parent company now selling CBD vapes
British American Tobacco is selling flavored CBD vapes in the United Kingdom as it eyes new products beyond tobacco and nicotine. But the parent company of Lucky Strike says it is not ready to enter the THC market yet. The company’s Chief Marketing Officer, Kingsley Wheaton, told CNBC this week that CBD is an “exciting… Continue reading Lucky Strike’s parent company now selling CBD vapes
CBD exec’s blank-check effort nets $115 million
A blank-check investment company led by the co-CEO of North Carolina CBD maker cbdMD has raised $115 million to invest in consumer goods. The new blank-check company, Adara, did not mention cannabinoid products in its November filing with the U.S. Securities and Exchange Commission. Instead, the company says it plans to invest in “companies in… Continue reading CBD exec’s blank-check effort nets $115 million
CBD brand hires former FDA executive to oversee regulatory initiatives
North Carolina CBD maker cbdMD has hired Sibyl Swift, a former U.S. Food and Drug Administration official as a consultant to lead the company’s regulatory efforts and prepare products for certifications. Swift served in various roles at the FDA from 2014 to 2020, most notably as the associate director for research and strategy in the… Continue reading CBD brand hires former FDA executive to oversee regulatory initiatives
AOSCA review board clears 4 new CBD-dominant seeds
A publicly traded California biotech company announced Tuesday that four of its hemp seed varieties have been aproved by the national variety board of the Association of Official Seed Certifying Agencies. Davis-based Arcadia Biosciences received eligibility for certified seed production for its GoodHemp brand varieties including Rogue, Umpqua, Santiam and Potomac. All four varieties are… Continue reading AOSCA review board clears 4 new CBD-dominant seeds
CBD maker GW Pharma agrees to $7.2 billion acquisition by Ireland’s Jazz Pharmaceuticals
(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed cash-and-stock deal would be the largest… Continue reading CBD maker GW Pharma agrees to $7.2 billion acquisition by Ireland’s Jazz Pharmaceuticals
First Big Tobacco cannabis player backs out after bankruptcy
The first Big Tobacco company to join the hemp and marijuana industries is getting back out. Pyxus International, one of the world’s largest tobacco suppliers, said Thursday that it will focus on its more profitable tobacco and liquid nicotine products after filing for bankruptcy in June. Based in Morrisville, North Carolina, Pyxus was growing hemp… Continue reading First Big Tobacco cannabis player backs out after bankruptcy
Investor lawsuit against NY hemp biotech company tossed
A federal judge in New York has dismissed an investor’s lawsuit accusing a hemp biotech company of lying to promote its stock price. Based in Williamsville, 22nd Century Group researches the genetics of tobacco and cannabis plants and was accused of trying to manipulate its stock price through misrepresenting its business. Plaintiffs were seeking class-action status.… Continue reading Investor lawsuit against NY hemp biotech company tossed
Molson Coors, HEXO launch CBD drinks in Colorado
Molson Coors Beverage Co. says it has launched CBD drinks in Colorado through TRUSS CBD USA, its joint venture with HEXO Corp. The beverage line will be available in three flavors – Grapefruit Tarragon, Strawberry Hibiscus and Blueberry Lavender under the name, “Verywell,” Molson Coors and HEXO said Wednesday. The companies first partnered in 2018… Continue reading Molson Coors, HEXO launch CBD drinks in Colorado
Landing a Buyer: Executives who have closed M&A deals reveal what makes them commit
This story appears in the January issue of Marijuana Business Magazine. Acquisitions remain a key strategy for companies looking to enter or expand their reach within the cannabis industry, but sellers must be ready to seize such opportunities. Owners who would like to exit the hemp space or join larger conglomerates should be ready to: Decide whether to engage a broker. Ensure their financial information is ready for close… Continue reading Landing a Buyer: Executives who have closed M&A deals reveal what makes them commit
Aurora Cannabis breach exposes personal data of former, current workers
This story first appeared at Marijuana Business Daily. A data breach at Aurora Cannabis has exposed the personal information of an unknown number of the Canadian company’s current and former employees, Marijuana Business Daily has learned. An email sent to a victim of the data breach cites a Dec. 25 “cybersecurity incident during which unauthorized… Continue reading Aurora Cannabis breach exposes personal data of former, current workers
Charlotte’s Web says another labeling lawsuit should wait for FDA
Charlotte’s Web Holdings says that labeling lawsuits against CBD makers must wait while federal regulators consider how to regulate the hemp extract. The company made the argument last week in a federal court in California, where it is asking a judge to follow the direction of other federal judges and dismiss CBD labeling suits as… Continue reading Charlotte’s Web says another labeling lawsuit should wait for FDA